JPY 654.0
(-0.15%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 32.04 Billion | 32.84 Billion | 30.16 Billion | 26.61 Billion | 27.91 Billion |
Cost of Revenue | 25.18 Billion | 26.12 Billion | 23.4 Billion | 19.3 Billion | 20.97 Billion |
Gross Profit | 6.85 Billion | 6.71 Billion | 6.75 Billion | 7.31 Billion | 6.94 Billion |
Operating Expenses | 6.24 Billion | 6.2 Billion | 6.11 Billion | 6.2 Billion | 5.86 Billion |
Selling, General and Administrative Expenses | 5.81 Billion | 680 Million | 656 Million | 662 Million | 5.49 Billion |
Research and Development Expenses | - | - | - | - | - |
Other Expenses | 429 Million | 226 Million | 187 Million | 201 Million | - |
Cost and Expenses | 31.42 Billion | 32.32 Billion | 29.52 Billion | 25.51 Billion | 26.83 Billion |
Operating Income | 613 Million | 511 Million | 636 Million | 1.1 Billion | 956 Million |
Interest Expense | 7 Million | 7 Million | 8 Million | 8 Million | 9 Million |
Income Tax Expense | 293 Million | 277 Million | 309 Million | 449 Million | 371 Million |
Earnings before Tax | 994 Million | 815 Million | 836 Million | 1.35 Billion | 1.13 Billion |
Net Income | 700 Million | 537 Million | 526 Million | 903 Million | 763 Million |
Earnings Per Share Basic | 57.06 | 43.79 | 42.91 | 73.57 | 62.17 |
Earnings Per Share Diluted | 57.06 | 43.79 | 42.91 | 73.57 | 62.17 |
Weighted Average Shares Outstanding | 12.26 Million | 12.28 Million | 12.28 Million | 12.28 Million | 12.27 Million |
Weighted Average Shares Outstanding (Diluted) | 12.26 Million | 12.28 Million | 12.28 Million | 12.28 Million | 12.27 Million |
Gross Margin | 0.21 | 0.20 | 0.22 | 0.27 | 0.25 |
EBIT Margin | 0.04 | 0.05 | 0.06 | 0.08 | 0.06 |
Profit Margin | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 |
EBITDA | 1.3 Billion | 1.26 Billion | 1.43 Billion | 1.91 Billion | 1.64 Billion |
Earnings Before Tax Margin | 0.02 | 0.02 | 0.02 | 0.04 | 0.03 |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 5.81 Billion | 9.87 Billion | 32.04 Billion | 9.47 Billion | 6.29 Billion | 6.39 Billion |
Cost of Revenue | 4.43 Billion | 7.95 Billion | 25.18 Billion | 7.35 Billion | 4.85 Billion | 5.02 Billion |
Gross Profit | 1.37 Billion | 1.92 Billion | 6.85 Billion | 2.11 Billion | 1.44 Billion | 1.37 Billion |
Operating Expenses | 1.43 Billion | 1.64 Billion | 6.24 Billion | 1.66 Billion | 1.47 Billion | 1.45 Billion |
Selling, General and Administrative Expenses | 1.43 Billion | 153 Million | - | 203 Million | 179 Million | 172 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | 72 Million | 242 Million | 65 Million | 61 Million | 44 Million |
Cost and Expenses | 5.87 Billion | 9.6 Billion | 31.42 Billion | 9.01 Billion | 6.33 Billion | 6.47 Billion |
Operating Income | -56 Million | 277 Million | 613 Million | 453 Million | -35 Million | -82 Million |
Interest Expense | 2 Million | 2 Million | 7 Million | 1 Million | 3 Million | 1 Million |
Income Tax Expense | 83 Million | 106 Million | 293 Million | 146 Million | 21 Million | 20 Million |
Earnings before Tax | 339 Million | 316 Million | 994 Million | 538 Million | 119 Million | 21 Million |
Net Income | 255 Million | 209 Million | 700 Million | 392 Million | 98 Million | 1 Million |
Earnings Per Share Basic | 20.84 | 17.08 | - | 31.94 | 7.98 | 0.12 |
Earnings Per Share Diluted | 20.84 | 17.08 | - | 31.94 | 7.98 | 0.12 |
Weighted Average Shares Outstanding | 12.23 Million | 12.23 Million | 12.26 Million | 12.27 Million | 12.28 Million | 12.28 Million |
Weighted Average Shares Outstanding (Diluted) | 12.23 Million | 12.23 Million | 12.26 Million | 12.27 Million | 12.28 Million | 12.28 Million |
Gross Margin | 0.24 | 0.19 | 0.21 | 0.22 | 0.23 | 0.22 |
EBIT Margin | 0.02 | 0.05 | - | 0.07 | 0.04 | 0.02 |
Profit Margin | 0.04 | 0.02 | 0.02 | 0.04 | 0.02 | 0.00 |
EBITDA | 116 Million | 490 Million | - | 662 Million | 229 Million | 123 Million |
Earnings Before Tax Margin | -0.01 | 0.03 | 0.02 | 0.05 | -0.01 | -0.01 |
1338
3360
UNT
IUR
9746
MVNE